ANI Pharmaceuticals ANIP
$68.55 −$0.58 (-0.84%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $68.55 0.00%
Open$68.96
Prev close$69.13
Day range$68.28 – $70.20
Volume227.3K
Market cap$1.56B
P/E (TTM)13.6
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$290.78M+27.6% YoY
Operating profit$51.84M+127.0% YoY
Net profit$35.15M+32.1% YoY
Diluted EPS$1.51+33.6% YoY
Free cash flow$70.28M+85.5% YoY
Operating cash flow$83.79M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin61.1%
Operating margin15.3%
Net margin10.6%
Return on equity19.2%
Return on assets7.4%
Return on invested capital10.2%
Current ratio2.75
Liabilities / assets59.4%
Cash & investments$436.35M
Total debt$607.23M
Net cash (debt)-$170.88M
Free cash flow / sales19.2%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $290.78M | $266.04M | $237.46M | $883.37M | $247.06M |
| Total Operating Revenue | $290.78M | $266.04M | $237.46M | $883.37M | $247.06M |
| Cost of Revenue | $111.53M | $100.16M | $93.58M | $341.31M | $100.27M |
| Gross Profit | $179.25M | $165.89M | $143.88M | $542.06M | $146.79M |
| Operating Expense | $127.41M | $126.05M | $105.17M | $460.83M | $117.66M |
| Selling and Admin Expenses | $94.86M | $91.66M | $73.66M | $317.75M | $82.79M |
| Research & Development | $13.00M | $14.75M | $10.60M | $51.66M | $12.26M |
| Depreciation & Amortization & Depletion | $19.55M | $19.64M | $20.92M | $91.42M | $22.61M |
| -Depreciation & Amortization | $19.55M | $19.64M | $20.92M | $91.42M | $22.61M |
| Operating Profit | $51.84M | $39.84M | $38.71M | $81.23M | $29.13M |
| Net Non-Operating Interest Income (Expense) | -$3.06M | -$3.64M | -$3.77M | -$20.06M | -$4.41M |
| Non-Operating Interest Expense | $3.06M | $3.64M | $3.77M | $20.06M | $4.41M |
| Other Income (Expense) | $262,000.00 | $895,000.00 | $5.28M | $34.62M | $6.76M |
| Gain on Sale of Security | -$35,000.00 | $741,000.00 | $5.75M | $2.82M | $273,000.00 |
| Special Income (Charges) | $538,000.00 | $622,000.00 | $182,000.00 | $29.86M | $5.64M |
| -Less:Restructuring and Mergern & Acquisition | -$538,000.00 | -$622,000.00 | -$182,000.00 | -$31.01M | -$5.73M |
| -Less:Impairment of Capital Assets | $0.00 | – | – | $767,000.00 | $0.00 |
| -Gain on Sale of Property/Plant/Equipment | $0.00 | – | – | -$382,000.00 | -$87,000.00 |
| Other Non-Operating Income (Expenses) | -$241,000.00 | -$468,000.00 | -$651,000.00 | $1.93M | $850,000.00 |
| Pretax Profit | $49.04M | $37.10M | $40.22M | $95.79M | $31.48M |
| Tax | $13.89M | $12.39M | $10.73M | $17.45M | $3.99M |
| Net Profit | $35.15M | $24.71M | $29.49M | $78.34M | $27.49M |
| Profit from Continuing Operations | $35.15M | $24.71M | $29.49M | $78.34M | $27.49M |
| Net Income to Parent Company | $35.15M | $24.71M | $29.49M | $78.34M | $27.49M |
| Net Income to Common Stockholders | $35.15M | $23.00M | $29.49M | $70.22M | $20.53M |
| Basic EPS | $1.54 | $1.09 | $1.31 | $3.50 | $1.24 |
| Diluted EPS | $1.51 | $1.05 | $1.28 | $3.32 | $1.18 |
| Other Preferred Stock Dividends | – | $1.71M | – | $6.96M | – |
| Preferred Stock Dividends | – | – | – | $1.16M | $0.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $1.57B | $1.49B | $1.42B | $1.44B | $1.44B |
| Total Current Assets | $902.82M | $825.43M | $747.08M | $753.12M | $753.12M |
| Cash and Cash Equivalents & Short-Term Investments | $436.35M | $375.84M | $326.06M | $294.72M | $294.72M |
| -Cash and Cash Equivalents | $420.76M | $360.21M | $311.18M | $285.59M | $285.59M |
| -Short Term Investments | $15.59M | $15.63M | $14.89M | $9.13M | $9.13M |
| Receivables | $304.45M | $274.47M | $255.43M | $281.08M | $281.08M |
| -Accounts Receivable | $304.45M | $274.47M | $255.43M | $281.08M | $281.08M |
| Inventory | $136.41M | $143.15M | $143.47M | $143.07M | $143.07M |
| Restricted Cash | $35,000.00 | $35,000.00 | $36,000.00 | $36,000.00 | $36,000.00 |
| Other Current Assets | $25.58M | $31.94M | $22.09M | $23.19M | $23.19M |
| Total Non-Current Assets | $664.84M | $668.68M | $674.89M | $687.26M | $687.26M |
| Net PPE | $81.55M | $73.22M | $67.12M | $62.48M | $62.48M |
| Goodwill and Other Intangible Assets | $495.59M | $512.34M | $529.64M | $542.01M | $542.01M |
| -Goodwill | $62.48M | $62.48M | $62.48M | $62.48M | $62.48M |
| -Other Intangible Assets | $433.11M | $449.86M | $467.16M | $479.53M | $479.53M |
| Non-Current Deferred Assets | $74.67M | $71.50M | $66.56M | $69.07M | $69.07M |
| Other Non-Current Assets | $13.03M | $11.62M | $11.58M | – | – |
| Total Liabilities | $930.55M | $896.90M | $859.67M | $899.65M | $899.65M |
| Total Current Liabilities | $328.72M | $283.66M | $239.51M | $278.11M | $278.11M |
| Payables | $83.39M | $77.36M | $74.99M | $64.82M | $64.82M |
| -Accounts Payable | $74.42M | $73.83M | $69.69M | $62.58M | $62.58M |
| -Total Tax Payable | $8.98M | $3.53M | $5.30M | $2.24M | $2.24M |
| Current Accrued Expenses | $141.36M | $113.80M | $86.08M | $108.45M | $108.45M |
| Short-Term Debt and Capital Lease Obligation | $23.36M | $21.33M | $19.30M | $17.27M | $17.27M |
| -Current Debt | $23.36M | $21.33M | $19.30M | $17.27M | $17.27M |
| Current Provisions | $45.65M | $44.01M | $43.05M | $49.50M | $49.50M |
| Total Non-Current Liabilities | $601.83M | $613.25M | $620.16M | $621.54M | $621.54M |
| Long Term Debt and Capital Lease Obligation | $583.87M | $589.16M | $594.46M | $599.77M | $599.77M |
| -Long Term Debt | $583.87M | $589.16M | $594.46M | $599.77M | $599.77M |
| Other Non-Current Liabilities | $17.96M | $24.08M | $25.70M | $21.77M | $21.77M |
| Total Equity | $637.11M | $597.21M | $562.30M | $540.72M | $540.72M |
| Stockholders' Equity | $637.11M | $597.21M | $562.30M | $540.72M | $540.72M |
| Capital Stock | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 |
| -Common Stock | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $634.24M | $620.25M | $608.43M | $596.04M | $596.04M |
| Retained Earnings | $66.25M | $31.10M | $6.39M | -$23.10M | -$23.10M |
| Less: Treasury Stock | -$62.21M | -$53.82M | -$53.00M | -$33.25M | -$33.25M |
| Gains/Losses Not Affecting Retained Earnings | -$1.17M | -$327,000.00 | $479,000.00 | $1.03M | $1.03M |
| Prepaid Assets | – | – | – | $11.03M | $11.03M |
| -Gross PPE | – | – | – | $115.17M | $115.17M |
| -Accumulated Depreciation | – | – | – | -$52.69M | -$52.69M |
| Financial Assets | – | – | – | $13.71M | $13.71M |
| Other Current Liabilities | – | – | – | $167,000.00 | $167,000.00 |
| Non-Current Accrued Expenses | – | – | – | $0.00 | $0.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $83.79M | $56.67M | $58.38M | $185.23M | $30.37M |
| Net cash flow from continuing operations | $83.79M | $56.67M | $58.38M | $185.23M | $30.37M |
| Net Income from Continuing Operations | $35.15M | $24.71M | $29.49M | $78.34M | $27.49M |
| Depreciation & Depletion & Amortization | $19.55M | $19.64M | $20.92M | $91.42M | $22.61M |
| Deferred Tax | -$3.17M | -$4.94M | $2.52M | $14.24M | $2.36M |
| Other Non-Cash Items | $287,000.00 | $191,000.00 | $629,000.00 | -$27.90M | -$4.82M |
| Change in Working Capital | $20.31M | $6.40M | $382,000.00 | -$7.12M | -$26.85M |
| -Change in Receivables | -$30.05M | -$19.08M | $25.53M | -$58.53M | -$27.86M |
| -Change in Inventory | $6.72M | $305,000.00 | -$437,000.00 | -$5.96M | $3.73M |
| -Change in Prepaid Assets | $4.56M | -$10.33M | $2.69M | -$5.02M | -$4.46M |
| -Change in Payables and Accrued Expense | $32.01M | $22.23M | -$20.95M | $67.69M | $1.76M |
| -Change In Other Working Capital | $7.07M | $13.28M | -$6.45M | -$5.30M | -$30,000.00 |
| Net cash flow from investing | -$13.50M | -$3.05M | -$11.32M | -$34.32M | -$1.40M |
| Net Cash Flow from Continuing Investing Activities | -$13.50M | -$3.05M | -$11.32M | -$34.32M | -$1.40M |
| Net PPE Purchase and Sale | -$13.50M | -$3.05M | -$6.07M | -$13.84M | -$1.24M |
| Net Intangibles Purchase and Sale | $0.00 | $0.00 | -$5.25M | -$20.49M | -$159,000.00 |
| Financing Cash Flow | -$9.83M | -$4.65M | -$21.62M | -$9.94M | -$4.64M |
| Net Cash Flow from Continuing Financing Activities | -$9.83M | -$4.65M | -$21.62M | -$9.94M | -$4.64M |
| Net Issuance Payments Of Debt | -$4.06M | -$4.06M | -$4.06M | -$10.16M | -$4.06M |
| Cash Dividends Paid | $0.00 | $0.00 | $0.00 | -$1.16M | $0.00 |
| Proceeds from Stock Option Exercised | $1.30M | -$20.26M | $2.20M | $13.60M | $11.64M |
| Net Other Financing Charges | -$77,000.00 | – | – | -$26,000.00 | $0.00 |
| Ending Cash Balance | $420.79M | $360.25M | $311.21M | $285.62M | $285.62M |
| Net Change in Cash | $60.46M | $48.97M | $25.44M | $140.96M | $24.33M |
| Beginning Cash Balance | $360.25M | $311.21M | $285.62M | $144.89M | $262.65M |
| Effect of Exchange Rate Changes | $91,000.00 | $67,000.00 | $156,000.00 | -$233,000.00 | -$1.35M |
| Free Cash Flow | $70.28M | $53.62M | $47.05M | $150.90M | $28.96M |
| Net Common Stock Issuance | – | – | -$19.76M | -$12.21M | -$12.21M |
| Gain/Loss from Continuing Operations | – | – | – | $382,000.00 | $87,000.00 |
| Net Business Purchase and Sale | – | – | – | $0.00 | $0.00 |
No comments yet — be the first to weigh in on ANIP.
Sign in to join the discussion.